Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 50-30-6 | MDL No. : | MFCD00002418 |
Formula : | C7H4Cl2O2 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | MRUDNSFOFOQZDA-UHFFFAOYSA-N |
M.W : | 191.01 | Pubchem ID : | 5758 |
Synonyms : |
|
Num. heavy atoms : | 11 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.0 |
Num. rotatable bonds : | 1 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.42 |
TPSA : | 37.3 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -5.88 cm/s |
Log Po/w (iLOGP) : | 1.44 |
Log Po/w (XLOGP3) : | 2.23 |
Log Po/w (WLOGP) : | 2.69 |
Log Po/w (MLOGP) : | 2.79 |
Log Po/w (SILICOS-IT) : | 2.5 |
Consensus Log Po/w : | 2.33 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.56 |
Log S (ESOL) : | -2.77 |
Solubility : | 0.327 mg/ml ; 0.00171 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.65 |
Solubility : | 0.429 mg/ml ; 0.00225 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -3.01 |
Solubility : | 0.188 mg/ml ; 0.000986 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 1.19 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
70% | With oxalyl dichloride In dichloromethane; N,N-dimethyl-formamide at 0 - 20℃; for 2 h; Inert atmosphere | To a solution of 2, 6-dichlorobenzoic acid (0.1 g, 0.52 mmol) in DCM (5 mL) was added DMF (3.83 mg, 52.35 umol) at 0°C under N2, then oxalyl dichloride (0.20 g, 1.57 mmol) was added drop-wise at 0°C and the reaction mixture was stirred at 0 to 20°C for 2 hours. TLC (Petroleum ether: Ethyl acetate = 5:1, Rf= 0.77) showed the starting material was consumed completely. And the solvent was removed to give 2,6- dichlorobenzoyl chloride (0.11 g, 0.37 mmol, 70percent yield) which was used for next step directly. To 28g-int (65 mg, 0.17 mmol, HCl salt) and DIEA (87.3 mg, 0.68 mmol) in DCM (10 mL), was added drop-wise a solution of 2,6-dichlorobenzoyl chloride (88.43 mg, 0.42 mmol) in DCM (5 mL) at 0°C under N2. The reaction mixture was stirred at 0 - 20°C for 16 hrs after which LCMS indicated that 28h-int was present and 28g-int was consumed. The solvent was removed and the residue was purified by prep-HPLC to give pure 28h-int; LCMS (ESI+): m/z 521.3 (M+H)+, RT: 1.1 min.HPLC purification conditions: Gilson 281 semi-preparative HPLC system; Mobile phase: A: TFA/ H2O = 0.075percent v/v; B: ACN (gradient of B: 20percent at T= 0 to 40percent at T = 12 min); Column: YMC-Actus Triart C18150 x 305u; Flow rate: 20 mL/ min; Monitor wavelength: 220 & 254 nm. |
Yield | Reaction Conditions | Operation in experiment |
---|---|---|
88% | at 20 - 55℃; for 1 h; | Step a: Synthesis of 2,6-dichloro-3-nitro-benzoic acid2,6-Dichloro-benzoic acid (10g, 52 mmol) was treated with a previously stirred mixture of nitric acid (15 mL) and sulfuric acid (30 mL) at 55 °C for 30 minutes followed by stirring at room temperature for 30 minutes. The reaction mixture was poured in ice cold water (1 L) and the solid obtained was filtered and dried to afford the product (9 gm). The filtrate was extracted with ethyl acetate (2 χ 200 mL). The combined organic layer was dried over anhydrous sodium sulphate and concentrated to dryness to yield more product (2 gm). (1 1 g, 88percent).1H NMR (400 MHz, MeOH-c/4): δ 7.98 (d, J=8.8 1 H), 7.67 (d, J=8.8 1 H). |
43% | With nitric acid In sulfuric acid | (i) 2,6-dichloro-3-nitrobenzoic acid The procedure described in K. Lehmstedt and K. Schrader, Chem. Berichte 70, 1526, (1937) was used. From 28.23 g (148 mmol) of 2,6-dichlorobenzoic acid, 75 mL of sulfuric acid, 6.75 mL of fuming nitric acid in 22.5 mL of sulfuric acid at 70°-90° C. was obtained 29.48 g of crude nitrated product. Crystallization from toluene afforded 14.92 g (43percent) of 2,6-dichloro-3-nitrobenzoic acid; mp 133°-135° C. |
[ 83277-23-0 ]
2,4-Dichloro-3-methylbenzoic acid
Similarity: 0.96
[ 153203-80-6 ]
3,5-Dichloro-4-formylbenzoic acid
Similarity: 0.94
[ 83277-23-0 ]
2,4-Dichloro-3-methylbenzoic acid
Similarity: 0.96
[ 153203-80-6 ]
3,5-Dichloro-4-formylbenzoic acid
Similarity: 0.94
[ 83277-23-0 ]
2,4-Dichloro-3-methylbenzoic acid
Similarity: 0.96
[ 153203-80-6 ]
3,5-Dichloro-4-formylbenzoic acid
Similarity: 0.94